Abstract
Today's market requirements drive companies in all industries to find ways to become more competitive, reduce project time lines and keep costs low. We at Genzyme Corporation's new Allston Landing Biopharmaceutical Manufacturing Facility have used standards — such as Instrument Society of America (ISA) draft standards for Batch Control Systems Models and Technology (ISA dSP88.01) — to save engineering time, money and help us meet our Food and Drug Administration (FDA) regulatory objectives with respect to implementation of a process management system.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
